Report - Phase 1 study of enavatuzumab, a first-in-class humanized ... · 10/20/2017 · every 2 weeks, on days 1 and 15 of each 4-week treatment cycle. The starting dose was 0.1 mg/kg with

Please pass captcha verification before submit form